3 ms·
"Part of the problem may be that wafer fab people and drug production people don't talk to each other much." - Another part of the problem is probably regulatio
by danvoell 6y ago
"Part of the problem may be that wafer fab people and drug production people don't talk to each other much." - Another part of the problem is probably regulation. Water companies don't want to inadvertently bypass FDA regulation. Drug production folks don't want to teach water folks the FDA approval process, such that, they could become future competition.... Sheer speculation.
- vmception 6y agowhether they actively think about it or not, the disincentives are there and should be addressed
- Robotbeat 6y agoAnd a pandemic is a good time to put an FDA bureaucrat, an army logistics expert, a manufacturing expert, and a drug expert along with unlimited funding on a private jet that can fly out to all these companies with a federal order signed by the president with authorization from Congress compelling companies to cooperate and with authority to cut through all red tape and IP law (with appropriate manpower to work with companies to ensure everything is done safely). Find every bottleneck and immediately fly out to the next company.
- hoseja 6y agoDo you really think government has power over companies anymore, and not the other way around? Future pharma profits must be protected at all costs. This "nationalizing essential drugs" business could set a dangerous precedent after all.